Role of mitochondrial dysfunction in Alzheimer's disease

Journal of Neuroscience Research

Volumn 70, Issue 3, 2002, Pages 357-360

  Castellani, Rudy ^a   Hirai, Keisuke ^b   Aliev, Gjumrakch ^a   Drew, Kelly L ^c   Nunomura, Akihiko ^d   Takeda, Atsushi ^e   Cash, Adam D ^a   Obrenovich, Mark E ^a   Perry, George ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^c UNIVERSITY OF ALASKA FAIRBANKS   (United States)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Mitochondria; Oxidative stress

Indexed keywords

CALCIUM; MITOCHONDRIAL DNA;

ALZHEIMER DISEASE; APOPTOSIS; CALCIUM HOMEOSTASIS; CYTOCHROME C OXIDASE DEFICIENCY; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; GENETIC DISORDER; HUMAN; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CYTOCHROMES; DNA, MITOCHONDRIAL; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUTATION; NEURONS; OXIDATIVE STRESS;

EID: 0037010312     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10389     Document Type: Review

References (27)

1. Beal MF. 2000. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 23:298-304.
2. Blass JP. 2000. The mitochondrial spiral: An adequate cause of dementia in Alzheimer syndrome. Ann N Y Acad Sci 924:170-183.
3. Blass JP, Brown AM. 2000. Lower activity of Krebs cycle enzymes than of electron transport in human brain: Disease implications. Neurobiol Aging 21 (Suppl):81.
4. Blass JP, Gibson GE. 1999. Cerebrometabolic aspects of delirium in relationship with dementia. Dement Geriatr Cogn Disord 10:335-338.
5. Castellani R, Perry G, Harris PLR, Smith MA. 2000. Iron sequestration by Lewy bodies of Parkinson's disease and diffuse Lewy body disease. Acta Neuropathol 100:111-114.
6. Davis RE, Miller S, Hermstadt C, Ghosh SS, Fahy E, Shinobu L, Galasko D, Twhal LJ, Beal MF, Howell N, Parker WD Jr. 1997. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci USA 94:4526-4531.
7. Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonejura Y, Konishi J. 1994. Altered cerebral energy metabolism in Alzheimer's disease: A PET study. J Nuclear Med 35:1-6.
8. Gibson GE, Pulsinelli WA, Blass JP. 1981. Brain dysfunction in mild to moderate hypoxia. Am J Med 70:1247-1254.
9. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PLR, Jones PK, Petersen RB, Perry G, Smith MA. 2001. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21:3017-3023.
10. Hirano M, Shtilbans A, Mayeux R, Davidson MM, DiMauro S, Knowles JA, Schon EA. 1997. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc Natl Acad Sci USA 94:14894-14899.
11. Holt IJ, Harding AE, Morgan-Hughes JA. 1988. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717.
12. Hoyer S. 1993. Intermediary metabolism disturbance in AD/SDAT and its relation to molecular events. Prog Neuropsychopharmacol Biol Psychiatry 17:199-228.
13. Hutchin TP, Heath PR, Pearson RC, Sinclair AJ. 1997. Mitochondrial DNA mutations in Alzheimer's disease. Biochem Biophys Res Commun 241:221-225.
14. King MP, Attardi G. 1989. Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 246:500- 503.
15. Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Change LJ, Wilson JM, DiStefano LM, Nobrega JN. 1992. Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 59:776-779.
16. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. 1997. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42:85-94.
17. Mutisya EM, Bowling AC, Beal MF. 1994. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 63:2179-2184.
18. Parker WD Jr, Boyson SJ, Parks JK. 1989. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26:719-723.
19. Smith MA, Harris PLR, Sayre LM, Perry G. 1997a. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94:9866-9868.
20. Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G. 1997b. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17:2653-2657.
21. Smith MA, Rottkamp CA, Nunomura A, Raina A, Perry G. 2000. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 1502:139-144.
22. Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP Jr, Davis RE, Parker WD Jr. 1997. Cybrids in Alzheimer's disease: A cellular model of the disease? Neurology 49:918-925.
23. Tanno Y, Okuizumi K, Tsuji S. 1998. mtDNA polymorphisms in Japanese sporadic Alzheimer's disease. Neurobiol Aging 19(Suppl):47-55.
24. Wallace DC. 1999. Mitochondrial diseases in man and mouse. Science 283:1482-1488.
25. Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD. 1997. Ancient mtDNA sequences in the human nuclear genome: A potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 94:14900-14905.
26. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ II, Nikoskelainen EK. 1988. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427-1430.
27. Zsurka G, Kalman J, Csaszar A, Rasko I, Janka Z, Venetianer P. 1998. No mitochondrial haplotype was found to increase risk for Alzheimer's disease. Biol Psychiatr 44:371-373.